Keeps BioPharma

Keeps BioPharma FCF per Share

The Free Cash Flow per Share of Keeps BioPharma (256940.KQ) as of Oct 29, 2026 is -2,480.69 KRW. In the previous year, Free Cash Flow per Share was -100.90 KRW — a change of 2,358.61% (lower).

FCF per Share

-2,480.69KRW

YoY

2,358.61%

Last updated:

Free Cash Flow per Share of Keeps BioPharma is 2025 -2,480.69 KRW. Free Cash Flow per Share of Keeps BioPharma was 2024 -100.90 KRW. It decreases by 2,358.61% lower compared to the previous year.

The Keeps BioPharma FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-227.81 KRW
Jan 1, 2019
-58.74 KRW
Jan 1, 2020
-181.25 KRW
Jan 1, 2021
-456.99 KRW
Jan 1, 2022
-51.32 KRW
Jan 1, 2023
-60.16 KRW
Jan 1, 2024
-100.90 KRW
Jan 1, 2025
-2,480.69 KRW
The Keeps BioPharma FCF per Share history
YEARFCF per ShareYoY
-2,480.69KRW+2,358.61%
-100.90KRW+67.72%
-60.16KRW+17.23%
-51.32KRW-88.77%
-456.99KRW+152.13%
-181.25KRW+208.58%
-58.74KRW-74.22%
-227.81KRW-149.78%
457.59KRW+781.26%
51.92KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Keeps BioPharma Stock analysis

What does Keeps BioPharma do? Keeps BioPharma Inc, operating under the KPS Corp brand, is headquartered in Hwaseong, South Korea. Listed on the stock exchange in December 2016, the company engages in the manufacture and sale of specialized machinery for flat panel displays. With a workforce of 49 employees, its product portfolio includes mask stretchers, support mask stretchers, total pitch inspection systems, open mask tension welders, lamination and de-lamination systems, inkjet printers, diffusion systems, and panel inspection systems. The firm operates within the Information Technology sector, specifically in the Semiconductors industry, providing essential equipment for display manufacturing processes. Keeps BioPharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Keeps BioPharma stock

Free Cash Flow per Share of Keeps BioPharma is -2,480.69 KRW in 2025.

Free Cash Flow per Share of Keeps BioPharma changed from -100.90 KRW to -2,480.69 KRW, representing a 2,358.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Keeps BioPharma since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Keeps BioPharma

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Keeps BioPharma